Clinical Development Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
AEZS | C | AEterna Zentaris Inc. | -2.42 | |
AFMD | F | Affimed Therapeutics B.V. | 7.14 | |
AGRX | F | Agile Therapeutics, Inc. | -0.82 | |
ALNY | C | Alnylam Pharmaceuticals, Inc. | -1.07 | |
AMPE | F | Ampio Pharmaceuticals, Inc. | -0.94 | |
APRE | D | Aprea Therapeutics, Inc. | 3.54 | |
ATRA | F | Atara Biotherapeutics, Inc. | -1.28 | |
AUPH | D | Aurinia Pharmaceuticals Inc | 0.74 | |
AXSM | B | Axsome Therapeutics, Inc. | -1.05 | |
BBIO | D | BridgeBio Pharma, Inc. | -2.91 |
Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Information Technology Services Medical Devices
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
BBP | C | BioShares Biotechnology Products Fund | 6.25 | |
GERM | C | ETFMG Treatments Testing and Advancements ETF | 5.57 | |
BTEC | C | Principal Healthcare Innovators Index ETF | 5.34 | |
XPH | F | SPDR S&P Pharmaceuticals ETF | 4.86 | |
PILL | F | Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF | 4.07 |
Compare ETFs
- Clinical Development
Clinical development is the process of developing a new drug, medical device, or diagnostic test from the initial concept to the point of regulatory approval. It involves a series of steps, including preclinical research, clinical trials, regulatory review, and post-marketing surveillance. The goal of clinical development is to demonstrate the safety and efficacy of a product in order to obtain regulatory approval for marketing.
Popular Now
Recent Comments
- ZealousTrout235 on New Scans: Strong, Oversold Stocks and Weak, Overbought Stocks
- TraderMike on Market Recap for Tuesday, May 21, 2024
- CharmingMole371 on Market Recap for Tuesday, May 21, 2024
- TraderMike on IZM
- SuccessfulGerbil321 on IZM
From the Blog
Featured Articles